by PharmacyChecker.com | Oct 31, 2011 | Drug Prices
While millions of Americans cannot afford brand name drugs in the United States, clearly this is not the case for generics – and the prices here keep getting lower! Marc’s, an Ohio-based retail pharmacy, has dropped prices for their generic drugs to a record breaking low – now charging just $1.98 for 30-day supplies of some of their generic drugs. Twenty-seven different generics are offered at this price.
Marc’s low-cost pricing comes as a response to their retail competition doing the same. In order to compete with chain store rivals like Target, Wal-mart and Kmart, smaller, local pharmacies are offering some of the lowest prices. Another example, Discount Drug Mart, – also in Ohio – dropped many of their generics to $1.99 for a month’s supply; this led Marc’s to sneak in at a penny less.
If you’re buying online, Costco.com has very low generic drug prices as well. You can compare prices on www.pharmacychecker.com.
Tagged with: Costco, Drug Prices, generic drugs, generics, Kmart, local, low-cost, Marc's, Ohio, Online Pharmacies, Target, United States, Wal-Mart
by Gabriel Levitt, President, PharmacyChecker.com and Prescription Justice | Oct 20, 2011 | Drug Prices
The simple answer is that tens of millions of Americans cannot afford prescription drugs here in the United States because they’re too expensive. Meanwhile, drug prices outside the U.S. are much lower – often 80% lower. Americans skipping or not taking prescription drugs is a national emergency largely going ignored in our healthcare debate.
Here are the facts about Americans skipping medication due to drug prices:
1. 25 million Americans did not take prescribed medication in 2009 due to cost, according to the U.S. Centers for Disease Control and Prevention. From 1997 to 2009, the percentage of Americans not taking their medications due to cost nearly doubled increasing from 4.8 to 8.4%.
Source: National Center for Health Statistics 2011. http://www.cdc.gov/nchs/data/hus/hus10.pdf#highlights
2. 48 million Americans ages 19-64 did not fill a prescription due to cost in 2010, according to the Commonwealth Fund – a 66% increase since 2001.
Source: The Commonwealth Fund 2010 Biennial Health Insurance Survey, http://www.commonwealthfund.org/Surveys/2011/Mar/2010-Biennial-Health-Insurance-Survey.aspx.
3. 3.4 million Medicare enrollees stop taking their medication due to the coverage gap.
Source: Polinski JM, Shrank WH, Huskamp HA, Glynn RJ, Liberman JN, et al. 2011 Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap. PLoS Medicine.
4. Prescription non-adherence adds $290 billion to America’s healthcare costs.
Source: U.S. Food and Drug Administration. 76 FR 12969. March 2011. http://www.federalregister.gov/articles/2011/03/09/2011-5287/campaign-to-improve-poor-medication-adherence-u18.
Access our RxSOS fact sheet here.
Tagged with: Commonwealth Fund, coverage gap, Drug Prices, FDA, FDA warnings, healthcare, international pharmacies, Medicare, National Center for Health Statistics, PLoS, prescription non-adherence, prescriptions, Public Library of Science, safety, U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration, United States
by PharmacyChecker.com | Oct 10, 2011 | Drug Prices, Medicare Drug Plans
An article published last week in Reuters suggests that Medicare Part D drug plans may be dropping premium prices – an effect of the healthcare reform law which could greatly benefit seniors if they shop around. Reevaluating your Medicare drug plan yearly during the open enrollment period is always a good idea, but this year plan selection could make a big difference.
Although we reported in August that plan premiums will not raise in 2012, Avalere Health, a health policy consulting firm, finds that while 10 of the top Part D plans will lower prices, six plans will raise premiums. However, the good news is that in the larger picture Avalere “projects that average premiums for both prescription drug and Advantage plans will fall 4 percent for 2012.” Because of the 2010 heath reform law, Dan Mendelson, Avalere Health’s CEO, is calling this a “year of change.” He tells Reuters, “It’s a year where patients really need to shop.”
MedicareDrugPlans.com provides ratings and reviews – along with basic plan information such as deductibles and premiums– for consumers to access during their research period. Ratings and comments help Medicare enrollees understand the pros and cons of a plan, and user comments and forum posts give details on what other Americans experienced with their plans.
Open enrollment will be from October 15th – December 7th this year, a change from previous years meant to give Medicare enough time to process all changes and new enrollees, and for consumers to manage their health needs before the busy holiday season.
Tagged with: Avalere Health, deductibles, Drug Prices, Medicare, Medicare Drug Plans, Medicare Part D, medicaredrugplans.com, Open Enrollment, premiums, Reuters, save money
by PharmacyChecker.com | Oct 3, 2011 | Drug Prices
Last week, Roger Bate, an economist and expert in counterfeit drugs with the American Enterprise Institute, wrote an article called “Google’s Ad Freedom Wrongly Curtailed.” Bate’s piece shows how banning safe foreign online pharmacies from advertising on Google and elsewhere is not only unethical but will lead to sub-optimal health outcomes. As we wrote at the end of August, the non-prosecution agreement between the U.S. Department of Justice (DOJ) and Google, in which the search engine was fined $500 million for allowing rouge Canadian sites to advertise controlled substances, is good because it forces Google to now block dangerous rogue online pharmacies from advertising. At the same time, however, it’s bad because it appears to prevent Google from allowing safe and affordable Canadian-based online pharmacies form advertising as well.
The DOJ/Google settlement appears to reflect the false rhetoric espoused by the U.S. government and pharmaceutical industry that only U.S. online pharmacies can be safe. Bate knows this is not true based on his own empirical studies, which found that properly credentialed non-U.S. online pharmacies sell genuine medication at a lower cost and require a prescription. By blocking safe Canadian pharmacies from advertising to Americans on Google, it is more difficult for needy Americans to find them. Bate writes:
Google’s current policy removes the potentially lethal sellers, but by disallowing credentialed foreign sites from advertising it will harm public health. The tens of millions of uninsured Americans who cannot afford their drugs will go online to circumvent this obstruction. If they are unaware of pharmacychecker.com’s credentialing, they will play Russian roulette and may end up buying a lethal product.
With media outlets and politicians inundated with a voracious pharmaceutical industry public relations assault that seeks to paint all non-U.S. online pharmacies as rogue, the victim here is the American seeking affordable medication online because he or she can’t afford it here at home. Bate wrote: “What is surprising is that independent groups, like Consumer Reports and AARP, have bought into this industry rhetoric or have failed to properly explain to their members that foreign doesn’t necessarily mean dangerous.” (more…)
Tagged with: AARP, adSense, advertising, AEI, American Enterprise Institute, Americans, Canada, Canadian pharmacies, Consumer Reports, controlled substances, Department of Justice, DOJ, Google, Online Pharmacies, pharmacychecker.com, Roger Bate, rogue pharmacies, safe pharmacies, United States
by Gabriel Levitt, Vice President, PharmacyChecker.com and Margaret Rode, PharmacyChecker.com | Aug 31, 2011 | Drug Prices, Healthcare Reform
A new report by the Commonwealth Fund, from their 2010 Biennial Health Insurance Survey, shows that 48 million Americans, ages 19-64, did not fill a prescription due to cost in 2010, up from 29 million in 2001 – a 66% increase. The study includes both insured and uninsured Americans but does not include children and seniors. The study indicates that the recession has greatly exacerbated the national crisis of prescription non-adherence (skipping medications), as nine out of 16 million Americans who have lost their job have also lost their health insurance.
It is difficult to estimate the sickness and even death that has resulted from so many millions of Americans not taking their prescribed medication due to cost. As evidenced by the new report, the situation is particularly dire for uninsured Americans with chronic medical conditions, as 27 million “skipped doses or did not fill a prescription for their condition because of the cost.” (more…)
Tagged with: Affordable Care Act, Biennial Health Insurance Survey, chronic, Commonwealth Fund, consumer guide, health insurance, Medicare, Medicare Drug Plans, prescription costs, skipping medicine, United States
by Gabriel Levitt, Vice President, PharmacyChecker.com and Margaret Rode, PharmacyChecker.com | Aug 17, 2011 | Drug Prices, Medicare Drug Plans
An estimated 43,000 residents of Illinois will find it more difficult, if not impossible, to afford their prescription medication due to heavy budget cuts, according to the Chicago Tribune. Specifically, funding for the Illinois Cares Rx program, which subsidizes the cost of medicine and payments associated with Medicare drug benefits, will be cut in half, from $107.4 million to $53.7 million. Illinois Cares Rx includes people with a Medicare drug plan and others who have no drug benefits at all.
With the cuts in place beginning September 1st, 2011, the Illinois Cares Rx program will only be available to those residents earning 200 percent or less of the federal poverty level – or $21,780 annually, down from a higher threshold of 240%, or $27,610. Even the 173,500 remaining in the program will “face higher co-payments for prescriptions — in some cases, double the amount they were previously paying.” (more…)
Tagged with: Chicago Tribune, consumer guide, discount drug cards, enrollment, generic drug programs, generics, Illinois, Illinois Cares Rx, Illinois Department of Healthcare and Family Services, Medicare, Medicare Drug Plans, PharmacyChecker Verification Program, prescriptions, Target, Wal-Mart
